✨ Free AI Report
Beryllium, LLC: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Beryllium, LLC
Company Research

Beryllium, LLC: Business Overview, Financials & Competitive Analysis

Beryllium, LLC scores 6/10 on the AskCyborg Cyborg Score (Solid). Specialized CRO with proven drug discovery expertise, strategic value as part of a large pharma portfolio, but limited independent market visibility as a private subsidiary. Beryllium operates a specialized and proven drug discovery platform with demonstrated scientific credibility (150+ published articles, 1% of protein data bank contributions). As a UCB.

What is Beryllium, LLC's industry? Beryllium, LLC (be4.com) operates in Drug Discovery Services. AskCyborg classifies Beryllium, LLC under Drug Discovery Services in its company registry.

Beryllium, LLC is a specialized drug discovery contract research organization (CRO) headquartered in Bedford, Massachusetts. The company provides research services and collaborative drug discovery platforms focused on...

6/ 10Solid

Cyborg Score thesis

Specialized CRO with proven drug discovery expertise, strategic value as part of a large pharma portfolio, but limited...

Read the full analyst-debate transcript →
Industry Drug Discovery Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest Beryllium, LLC Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Beryllium, LLC

AskCyborg analysts argue the bull and bear cases for Beryllium, LLC across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Beryllium, LLC OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Beryllium, LLC Overview

Pro stress-test →

Beryllium, LLC is a specialized drug discovery contract research organization (CRO) headquartered in Bedford, Massachusetts. The company provides research services and collaborative drug discovery platforms focused on protein engineering, expression and purification, functional biology, and structure-based drug design. Now a subsidiary of UCB (acquired June 2017), Beryllium serves leading pharmaceutical, biotechnology, and academic partners.

Strategic Profile

Pro stress-test →

Beryllium's competitive advantage lies in its biology-first, target-centric approach and deep expertise in gene-to-function services. The company leverages its proximity to Boston's biotech ecosystem and maintains a history of successful collaborations with major pharma players. As part of UCB, Beryllium's platform supports discovery programs in immune and central nervous system diseases.

Competitive Landscape

Pro stress-test →

Beryllium competes with other specialized drug discovery CROs and contract research organizations serving pharma and biotech clients. Key competitors include Envigo, Charles River Laboratories (preclinical services), and smaller regional CROs. Beryllium's advantage is its deep structural biology expertise and proven track record with major pharma clients, though it operates as a subsidiary with limited independent brand visibility.

Industry Context

Beryllium, LLC operates in Drug Discovery Services.

Key facts

Founded: 1999 · Headquarters: Bedford, MA, United States · Employees: 28 · Revenue: $1M–$10M (estimated) · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Beryllium, LLC.

  • Founded in 1999 with assets from Emerald Bio and deCODE Genetics, combining chemistry and structural biology expertise
  • Approximately 28 employees as of February 2026, suggesting focused boutique research model
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2017Acquired by UCB Pharma, Ltd., creating strategic integration with major biopharma partner
  • April 2015Expanded with new 24,000 sq ft research facility in Bedford, MA near Boston biotech hub
  • +1 moreTrack every material event for Beryllium, LLC as it happens. Explore monitoring →
Get alerted when Beryllium, LLC has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Beryllium, LLC with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Beryllium, LLC operates in Drug Discovery Services. See how the rest of the sector scores on the Cyborg framework.

Browse Drug Discovery Services research →
NEW · MCP server

Ask your AI assistant about Beryllium, LLC

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Beryllium, LLC and its top competitor on Cyborg Score”
“What did Beryllium, LLC do this quarter?”
“Is Beryllium, LLC a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Beryllium, LLC do?+
Beryllium, LLC is a specialized drug discovery contract research organization (CRO) headquartered in Bedford, Massachusetts. The company provides research services and collaborative drug discovery platforms focused on...
What is Beryllium, LLC's Cyborg Score?+
Beryllium, LLC has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Beryllium, LLC's main competitors?+
Named competitors include Charles River Laboratories, Envigo, Wugen. The full competitive landscape is in the AskCyborg report.
How can I get the full Beryllium, LLC research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Beryllium, LLC research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Beryllium, LLC over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual